Brief: Basilea Announces Zevtera (Ceftobiprole) Marketing Authorization In Brazil
July 12 (Reuters) - Basilea Pharmaceutica AG BSLN.S :
* BASILEA ANNOUNCES ZEVTERA® (CEFTOBIPROLE) MARKETING
AUTHORIZATION IN BRAZIL
Source text for Eikon: ID:nGNERwWWX
Further company coverage: BSLN.S
((frankfurt.newsroom@thomsonreuters.com;))
Recent news on Basilea Pharmaceutica AG, Allschwil
See all newsBrief: Basilea Pharmaceutica - Strong Cresemba Sales In Europe Trigger USD 37.5 Mln Milestone Payment
Basilea seen up after raising 2026 guidance
Brief: Basilea Expects 2026 Operating Profit Of CHF 115 Mln
Brief: Basilea Reports Presentation Of New Data For Fosmanogepix, Isavuconazole And Ceftobiprole At IDWeek 2026
RCS - Accession Theraptcs. - Accession Therapeutics: Board appointments